Cart
sales@molnova.com
Home - Products - Others - Other Targets - Bendazac

Bendazac

CAS No. 20187-55-7

Bendazac( Bendazolic acid | AF-983 )

Catalog No. M21078 CAS No. 20187-55-7

Bendazac is an anticataract drug. It may act by preventing protein denaturation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 37 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Bendazac
  • Note
    Research use only, not for human use.
  • Brief Description
    Bendazac is an anticataract drug. It may act by preventing protein denaturation.
  • Description
    Bendazac is an anticataract drug. It may act by preventing protein denaturation.(In Vitro):Bendazac is an anti-inflammatory agent endowed with protein antidenaturant properties effective for various inflammatory skin conditions. Bendazac has been shown to be a strong reacting substrate in a chemical oxidizing system, which mimics a physiological pathway of hydroxy radical generation.By using EPR spectroscopy of spin-labelled bovine serum albumin (BSA), Bendazac was shown to prevent the BSA denaturation induced by urea, heat and free radicals produced in the xanthine/xanthine oxidase system.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Bendazolic acid | AF-983
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    20187-55-7
  • Formula Weight
    282.29
  • Molecular Formula
    C16H14N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:56 mg/mL (198.38 mM)
  • SMILES
    O=C(O)COc1nn(Cc2ccccc2)c2ccccc12
  • Chemical Name
    2-((1-benzyl-1H-indazol-3-yl)oxy)acetic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Marques C Ramalho J S Pereira P et al. Bendazac decreases in vitro glycation of human lens crystallins. Decrease of in vitro protein glycation by bendazac[J]. Documenta Ophthalmologica 1995 90(4):395-404.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Polygalasaponin XXXI

    Onjisaponin F(Polygalasaponin XXXI) acts non-competitively against cyclic AMP phosphodiesterase, like papaverine; it also exhibits a prolongation effect on hexobarbital sleeping time in mice.

  • (+)-ORM-10921

    (+)-ORM-10921 is a conformation of ORM-10921 and can be used in chemical synthesis studies.

  • Acrivastine

    Acrivastine is a short-acting histamine 1 receptor antagonist.

Sign In Join Free